NEW YORK (GenomeWeb News) – Ezose Sciences today said that it will collaborate with Fast Forward, a subsidiary of the National Multiple Sclerosis Society, to discover biomarkers that may help diagnose multiple sclerosis, improve disease management, and help guide development of new MS medicines.
Under the alliance, Ezose will collaborate with Anthony Reder, a professor of neurology at the University of Chicago. Researchers will use Ezose's GlycanMap to discover new biomarkers associated with MS. The GlycanMap platform combines high-throughput glycan enrichment with specialized MALDI-TOF mass spectrometry and bioinformatics to identify and quantitate glycans in complex biological samples.
Pine Brook, NJ-based Ezose said that it will receive up to $390,000 from Fast Forward to support the studies. Further terms were not disclosed.